（文章来源：证券日报） 证券日报网讯 10月23日晚间，晨光生物发布公告称，公司于近日收到公司公开发行可转换公司债券的 持续督导保荐机构中原证券股份有限公司（简称"中原证券"）出具的《关于更换晨光生物持续督导保荐 代表人的函》，获悉中原证券原委派的保荐代表人封江涛先生因工作变动不再继续担任公司公开发行可 转换公司债券持续督导期间的保荐代表人，中原证券决定委派保荐代表人白林女士接替封江涛先生担任 公司持续督导期间的保荐代表人，继续履行持续督导职责。 ...

公司董事会对封江涛先生在公司持续督导期间所作的工作表示衷心的感谢。 特此公告 晨光生物科技集团股份有限公司 董事会 2025 年 10 月 23 日 证券代码：300138 证券简称：晨光生物 公告编号：2025—114 晨光生物科技集团股份有限公司 关于更换持续督导保荐代表人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 晨光生物科技集团股份有限公司（以下简称"公司"或"晨光生物"）于近 日收到公司公开发行可转换公司债券的持续督导保荐机构中原证券股份有限公 司（以下简称"中原证券"）出具的《关于更换晨光生物持续督导保荐代表人的 函》，获悉中原证券原委派的保荐代表人封江涛先生因工作变动不再继续担任公 司公开发行可转换公司债券持续督导期间的保荐代表人，中原证券决定委派保荐 代表人白林女士接替封江涛先生担任公司持续督导期间的保荐代表人，继续履行 持续督导职责。 本次保荐代表人变更后，公司公开发行可转换公司债券的持续督导保荐代表 人为钟坚刚先生和白林女士，持续督导期至中国证券监督管理委员会和深圳证券 交易所规定的持续督导义务结束为止。 附件：白林简历 白林女 ...

（文章来源：证券日报） 证券日报网讯晨光生物10月22日在互动平台回答投资者提问时表示，结合深交所信息披露的要求及公司 情况，公司在定期报告中披露每月末股东人数情况，敬请留意公司在指定信息披露媒体披露的定期报 告。 ...

证券代码：300138 证券简称：晨光生物 公告编号：2025—113 晨光生物科技集团股份有限公司 关于注销部分募集资金专户的公告 截至公告披露日，公司募集资金专户开立情况如下： | 2 | 中国银行股份有限公司曲 | 100835054447 | | 已销户 | | --- | --- | --- | --- | --- | | | 周支行 | | | | | 3 | 兴业银行股份有限公司石 | 572010100101566380 | | 已销户 | | | 家庄分行 | | | | | | 中国光大银行股份有限公 | 50520188000193885 | 天然植物综合提取一 | 已销户 | | 4 | 司邯郸分行 | | 体化项目（一期） | | | 5 | 中国农业银行股份有限公 | 50163401040001334 | | 已销户 | | | 司曲周县支行 | | | | | 6 | 沧州银行股份有限公司邯 | 6300120100000224700 | | 已销户 | | | 郸分行 | | | | | 7 | 中信银行股份有限公司海 | 8115801013600077553 | 红辣素精 ...

证券代码：300138 证券简称：晨光生物 公告编号：2025—112 晨光生物科技集团股份有限公司 关于子公司归还银行借款暨为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 晨光生物科技集团股份有限公司（以下简称"公司"）对合并报表范围内子 公司银行借款担保情况因业务进展发生了变动，现公告如下： 一、对外担保基本情况及进展 1、结合自身经营流动资金需求，经公司 2023 年年度股东大会决议，晨光生 物科技集团图木舒克有限公司（以下简称"图木舒克晨光"，系新疆晨光生物科 技股份有限公司全资子公司，穿透后为公司控股子公司）前期向上海浦东发展银 行股份有限公司喀什分行（以下简称："浦发银行"）提出 5,000 万元流动资金 借款申请。经过核查，浦发银行同意了图木舒克晨光的借款申请，担保方式为： 公司保证担保。 公司与浦发银行签署了《最高额保证合同》，被担保主债权本金余额不超过 伍仟万元；保证方式为：连带责任保证；保证范围为：主债权、利息、违约金、 损害赔偿金、手续费及其他为签订或履行本合同而发生的费用、以及债权人实现 担保权利和债权所产生 ...

市场走势 资料来源：最闻 国内市场主要指数 研究早观点 2025 年 10 月 21 日 星期二 | 指数 | | 收盘 | 涨跌幅% | 遇 | | --- | --- | --- | --- | --- | | 上证指数 | | 3,863.89 | 0.63 | | | 深证成指 | | 12,813.21 | 0.98 | | | 沪深 | 300 | 4,538.22.53 | 0 | | | 中小板指 | | 7,870.96 | 0.71 | | | 创业板指 | | 2,993.45 | 1.98 | | | 科创 | 50 | 1,367.90 | 0.35 | | | 资料来源：最闻 | | | | | 分析师： 彭皓辰 执业登记编码：S0760525060001 邮箱：penghaochen@sxzq.com 【今日要点】 【山证纺服】9 月社零数据点评-9 月国内社零同比增长 3.0%，化妆品 单月增速环比提升 【山证纺服】行业周报-老铺黄金天猫"双 11"表现强劲，361 度零售 流水延续健康增长 【公司评论】晨光生物(300138.SZ)：晨光生物 2025 年前三季报业绩预 告点 ...

| 市场数据：2025 年 10 月 | 17 日 | | --- | --- | | 收盘价（元）： | 14.41 | | 年内最高/最低（元）： | 14.90/7.94 | | 流通A股/总股本（亿）： | 3.98/4.83 | | 流通 股市值（亿）： A | 57.40 | | 总市值（亿）： | 69.61 | | 基础数据：2025 年 | 6 月 | 30 日 | | | | --- | --- | --- | --- | --- | | 基本每股收益(元)： | | | | 0.44 | | 摊薄每股收益(元)： | | | 0.44 | | | 每股净资产(元)： | | | | 6.85 | | 净资产收益率(%)： | | | | 6.68 | | 资料来源：最闻 | | | | | 冀泳洁 执业登记编码：S0760523120002 邮箱：jiyongjie@sxzq.com 王锐 执业登记编码：S0760524090001 邮箱：wangrui1@sxzq.com 公司近一年市场表现 事件描述 2025 年 10 月 13 日，公司发布前三季业绩预增公告，预计实现净利润为 2. ...

Core Insights - A total of 133 A-share listed companies have released performance forecasts for the first three quarters of 2025, indicating a significant level of market activity [1] - Among these, 9 companies, including Xinda Co., Chujian New Materials, Yinglian Co., Shobead, Guangdong Mingzhu, Rongzhi Rixin, Shenghe Resources, Limin Co., and Chenguang Biological, are expected to see their net profits increase by over 400% year-on-year [1] Group 1 - 133 A-share listed companies have published performance forecasts for the first three quarters of 2025 [1] - 9 companies are projected to have net profit growth exceeding 400% year-on-year [1] - Guangdong Mingzhu's performance forecast announcement led to a significant stock price increase, with the stock closing at a 6-day, 3-board rise [1]

Core Insights - The market's focus on corporate performance has significantly increased with the ongoing disclosure of Q3 reports, with 46 institutions conducting 195 "buy" ratings covering 140 stocks as of October 17 [2][8] - Among the stocks rated, Zhongchong Co. and Xiaoshangpin City received the highest number of ratings, with 16 and 9 institutions respectively [2][3] - Zhongchong Co. reported a revenue of 3.86 billion yuan for the first three quarters, a year-on-year increase of 21.05%, and a net profit of 333 million yuan, up 18.21% [2] Company Performance - Zhongchong Co. has successfully entered the North American market through its WANPY brand on Chewy, the largest pet e-commerce platform in North America, indicating ongoing channel development [2] - Among the 140 stocks rated, 32 reported a year-on-year increase in net profit for the first three quarters, with Shijia Photon and Chenguang Biotech showing net profit growth exceeding 100% [8] - Shijia Photon achieved a net profit of 300 million yuan, a staggering increase of 727.74%, driven by the rapid growth of the data communication market due to AI development [8] - Chenguang Biotech's estimated net profit for the first three quarters ranges from 278 million to 314 million yuan, reflecting a year-on-year growth of 344.05% to 401.55% [8] Industry Trends - The pharmaceutical and biotechnology sectors are seeing a surge in positive news, with new regulations aimed at promoting biomedical innovation and improving medical quality [5][6] - The electronic industry is also favored by institutions, with AI technology driving new growth, particularly in high-bandwidth memory (HBM) demand, which is expected to grow by 70% globally by 2025 [6] - The average increase in stock prices for the 140 rated stocks this year is 39.56%, with 14 stocks experiencing gains exceeding 100%, highlighting strong market performance [9]

Core Insights - 31 companies listed on the ChiNext board have released their performance forecasts for the first three quarters, with 25 companies expecting profit increases, representing 80.65% of the total [1] - The overall proportion of companies with positive forecasts (including profit increases and profit forecasts) stands at 87.10%, with only 4 companies expecting profit declines [1] Performance Forecasts - Among the companies with positive forecasts, 11 are expected to see net profit growth exceeding 100%, while 6 companies anticipate growth between 50% and 100% [1] - ShuoBeide (300322) is projected to have the highest net profit growth at 1285.82%, followed by Chenguang Biological (300138) at 372.80% and Ice River Network (300533) at 207.09% [1] Market Performance - Stocks of companies expecting profit growth have seen an average increase of 98.75% this year, with notable performers including Zhenyu Technology (300953) up 243.48%, Jinli Yongchang (300748) up 129.80%, and Guangku Technology (300620) up 105.43% [1] - Recent performance over the last five days shows Chenguang Biological (300138) up 10.87%, Jinli Yongchang (300748) up 3.47%, and Chuanjin Nuo (300505) up 1.20% [1] Company Performance Table - A detailed table lists companies with their respective codes, expected net profit growth percentages, latest closing prices, year-to-date performance, and industry classifications [1][2]